SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Erasca, Inc. (ERAS) has a negative trailing P/E of -39.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -2.56%.
Criteria proven by this page:
- VALUE (10/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -39.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -2.56%); analyst consensus target implies downside from the current price ($11.60, 35%).
- Trailing Earnings Yield -2.56% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $11.60 (-35% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ERAS
Valuation Multiples
P/E (TTM)-39.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio14.96
P/S Ratio0.00
EV/EBITDA-42.0
Per Share Data
EPS (TTM)$-0.44
Book Value / Share$1.15
Revenue / Share$0.00
FCF / Share$-0.34
Yields & Fair Value
Earnings Yield-2.56%
Dividend Yield0.00%
Analyst Target$11.60 (-35%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-172.2 |
0.00 |
-152.41 |
0.00 |
- |
| 2020 |
-20.4 |
-0.03 |
19.30 |
0.00 |
- |
| 2021 |
-15.1 |
-0.71 |
4.06 |
0.00 |
- |
| 2022 |
-2.2 |
-0.02 |
1.28 |
0.00 |
- |
| 2023 |
-2.6 |
0.04 |
1.01 |
0.00 |
- |
| 2024 |
-3.6 |
0.22 |
1.39 |
0.00 |
- |
| 2025 |
-8.5 |
0.23 |
3.24 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.01 |
$0.00 |
$-10.74M |
- |
| 2020 |
$-0.93 |
$0.00 |
$-173.07M |
- |
| 2021 |
$-0.16 |
$0.00 |
$-150.09M |
- |
| 2022 |
$-0.24 |
$0.00 |
$-238.16M |
- |
| 2023 |
$-0.10 |
$0.00 |
$-125.04M |
- |
| 2024 |
$-0.07 |
$0.00 |
$-161.65M |
- |
| 2025 |
$-0.44 |
$0.00 |
$-124.55M |
- |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.43 |
$-0.77 – $-0.35 |
$7.52M |
$7.52M – $7.52M |
8 |
| 2027 |
$-0.52 |
$-0.62 – $-0.45 |
$428.57K |
$428.57K – $428.57K |
7 |
| 2028 |
$-0.66 |
$-0.91 – $-0.50 |
$3.67M |
$3.67M – $3.67M |
6 |
| 2029 |
$-0.77 |
$-0.77 – $-0.77 |
$35.27M |
$35.27M – $35.27M |
4 |
| 2030 |
$-0.40 |
$-0.40 – $-0.40 |
$299.27M |
$299.27M – $299.27M |
2 |
